Monday, December 12, 2011

Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.

If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines


Get up-to-the-minute Globe Business Updates   |  More Business News
 
ADVERTISEMENT

Mon. Dec. 12, 2011

WBZ-TV unveils new look
WBZ-TV unveils a new news set, graphics, and music as a rebranding of the station. The station, which ranks second or third in newscast ratings, hasn’t had such a major facelift in a decade. WBZ-TV Channel 4 is unveiling a new news set and graphics look today during its 5 p.m. newscast today. The station’s sunny yellow and blue hues are now amber and blue and it’s using the familiar corporate CBS eye logo for its graphic packages and logos.

Sun Life to stop selling US annuities, cuts 800 jobs
Sun Life Financial Inc., Canada’s third-largest insurer, plans to stop selling variable annuities and individual life insurance products in the United States and will cut 800 jobs there as it shifts focus to Canada and Asia. Sun Life expects to record costs of about $75 million in Canadian dollars ($73 million) to $100 million Canadian from the changes, a portion of which will be in the fourth quarter, the Toronto-based company said. The insurer will also take a writedown of about $97 million Canadian.

Cubist Pharmaceuticals completes deal for Adolor
Cubist Pharmaceuticals Inc. said today that it has completed its acquisition of fellow drugmaker Adolor Corp. for about $221 million. Lexington-based Cubist said it bought all of Exton, Pa.-based Adolor’s outstanding shares for $4.25 per share in cash. Adolor shareholders will also receive up to an additional $4.50 per share if certain milestones are met in the development of a potential treatment for chronic, opioid-induced constipation, Cubist said. Effective today, Adolor common stock ceased trading on the Nasdaq stock exchange.

Mass. gas prices drop another penny
The average price for gas in Massachusetts is $3.279 a gallon in the latest weekly AAA survey, down 1 cent from the previous week’s average, AAA Southern New England said today. This is the fourth straight week of decreases, and this week’s average is 12 cents lower than the average of a month ago, according to AAA Southern New England. The current national average is $3.27 a gallon.

Film star Renée Zellweger puts her Conn. retreat up for sale for $1.5m
Film star Renée Zellweger is putting her retreat in Pomfret, Conn., up for sale. The nearly 39-acre property has an asking price of $1.5 million, said Coldwell Banker Residential Brokerage in New England, which is marketing the place. The property includes a “recreation barn” and a helicopter landing area. The main residence has about 3,400 square feet of living space, and it is thoughtfully accessorized with a guest cottage.

American Tower to buy wireless tower sites in Mexico
American Tower Corp., a Boston-based owner and operator of broadcast and wireless communications sites, said it has agreed to buy up to about 2,500 towers from Telefónica’s Mexican subsidiary, Pegaso PCS, S.A. de C.V., for $500 million, excluding value added tax. The acquisition, which is subject to regulatory approval, would nearly double the company’s portfolio in Mexico. The company added that it expects to acquire a substantial majority of the towers during the fourth quarter.

Amag in line for a $3m milestone payment
Amag Pharmaceuticals Inc. of Lexington is in line to receive a $3 million milestone payment under a licensing agreement for its iron-replacement drug. The drug is Feraheme, and it has been available in the United States for more than two years. The Canadian unit of the Japanese drug company Takeda has an exclusive license to market Feraheme for all therapeutic applications in Canada. Amag announced today that Canadian regulators have granted marketing approval for Feraheme.

InVivo’s Robert S. Langer wins Economist bioscience award for innovation
InVivo Therapeutics Holdings Corp. today congratulated company cofounder Robert S. Langer for his selection as the recipient of the 2011 the Economist annual innovation award in bioscience. Langer was cited for his work on controlled-release drug delivery and tissue engineering. The award recognizes people in such fields as bioscience, computing and telecommunications, energy and the environment, social and economic innovation, and business-process innovation.

Mass. Governor Deval Patrick returning after trade mission
Governor Deval Patrick is returning to Beacon Hill after a nine-day trade mission to South America that included tours of Chile and Brazil. Patrick, state officials, and corporate leaders made the trip to strengthen business and cultural ties with the region. He returns to the Massachusetts Statehouse today. Patrick signed an agreement during the trip with Chilean President Sebastian Pinera intended to expand the collaboration between Massachusetts and Chile in the clean energy, biotechnology, and education business sectors.

Mass AG Martha Coakley: NRC must take 2nd look at Japan accident
Massachusetts Attorney General Martha Coakley is pushing federal regulators to take another look at the Fukushima Daiichi nuclear disaster in Japan as they consider relicensing the Pilgrim Nuclear Power Station. Coakley today appealed to the Nuclear Regulatory Commission to review the Atomic Safety and Licensing Board’s refusal to consider the implications of the Fukushima disaster last March. Coakley said there are similarities between the Fukushima and Pilgrim plants.

Fidelity Worldwide Investment’s Korhonen departs, 5 years after succeeding Bolton
Fidelity Worldwide Investment’s Jorma Korhonen, the asset manager who took over some of Anthony Bolton’s funds five years ago, has left the company amid slumping returns. Korhonen will be replaced by Jeremy Podger, Fidelity said in an e-mailed statement. Korhonen led Fidelity Global Special Situations Fund when it was split from Bolton’s U.K. Special Situations Fund in 2006. At the time, Bolton’s fund was valued at $12 billion and he’d managed it for 27 years, becoming Britain’s most successful money manager.

No comments:

Post a Comment